AstraZeneca is a global, science-led biopharmaceutical company headquartered in Cambridge, United Kingdom. Founded in 1999 through the merger of Sweden’s Astra AB and the UK’s Zeneca Group, the company focuses on the discovery, development, and commercialization of prescription medicines. Its mission is to improve health outcomes and transform lives through innovative medicines in areas such as oncology, cardiovascular, renal & metabolism, and respiratory & immunology. With over 80,000 employees worldwide, AstraZeneca operates in more than 100 countries and maintains a strong reputation for scientific excellence and a robust pipeline of new therapies.
In recent years, AstraZeneca has gained significant global recognition for its role in developing the COVID-19 vaccine in collaboration with the University of Oxford, contributing to pandemic response efforts worldwide. The company continues to invest heavily in research and development, with a focus on precision medicine and biologics. Its market position is reinforced by strong sales growth in oncology and other therapeutic areas, and it remains a key player in the pharmaceutical industry with a commitment to sustainability and equitable access to healthcare.